clinical trial · NCT04626596
A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)
Organon and Co·phase3·completed·n = 498
ContraceptionRadiopaque Etonogestrel (ENG) Implant
brief summary
The primary purpose of this study is to assess the efficacy and safety of the etonogestrel (ENG) contraceptive implant during participants' fourth and fifth years of use when used as the only method of contraception. The ENG implant is currently approved for a 3-year duration, and this study aims to confirm available evidence suggesting that the ENG implant remains highly effective when used up to 5 years.
started
Nov 19, 2020
primary completion
Dec 30, 2024
completion
Dec 30, 2024
last updated
Feb 18, 2026
official title
A Phase 3, Open-label, Multi-center, Single Arm Study to Assess Contraceptive Efficacy and Safety of the Etonogestrel (MK-8415) Implant During Extended Use From 3 Years After Insertion in Females 35 Years of Age or Younger
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol